Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Meptin Swinghaler and Ventolin MDI in stable asthma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Meptin Swinghaler (metaproterenol)
• Ventolin MDI (salbutamol)

Snippet

Sponsor: Taiwan Otsuka Pharm. Co., Ltd | Conditions: Asthma | Phase 3 | Status: COMPLETED